These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 2797570
1. Lomefloxacin sensitivities. Smith JM, Hashmi ZS. N Z Med J; 1989 Jul 26; 102(872):391. PubMed ID: 2797570 [No Abstract] [Full Text] [Related]
2. Lomefloxacin sensitivities. Smith JM, Hashmi ZS. N Z Med J; 1990 Jun 13; 103(891):277-8. PubMed ID: 2356052 [No Abstract] [Full Text] [Related]
3. In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents. Peddie BA. N Z Med J; 1989 Jun 14; 102(869):298. PubMed ID: 2733911 [No Abstract] [Full Text] [Related]
4. [In vitro evaluation of lomefloxacin]. Dette GA, Knothe H. Arzneimittelforschung; 1989 Aug 14; 39(8):832-5. PubMed ID: 2818672 [Abstract] [Full Text] [Related]
5. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone. Jones RN. J Chemother; 1989 Jul 14; 1(4 Suppl):165-7. PubMed ID: 16312353 [No Abstract] [Full Text] [Related]
7. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin. Azadian BS, Talboys CA, Roberts AP. J Chemother; 1989 Jul 14; 1(4 Suppl):176-7. PubMed ID: 16312357 [No Abstract] [Full Text] [Related]
8. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology]. Derevianko II, Lopatkin NA, Khodyreva LA, Kondrat'eva EM. Urol Nefrol (Mosk); 1998 Jul 14; (5):14-8. PubMed ID: 9820038 [No Abstract] [Full Text] [Related]
10. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative]. Koikeda S, Okabe H, Shibata H, Hase T, Nakanishi N, Okezaki E, Kato H, Masamune Y. Jpn J Antibiot; 1989 Jan 14; 42(1):193-9. PubMed ID: 2468799 [Abstract] [Full Text] [Related]
11. Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City. Durazo F, Resano F, Gonzalez MA. Diagn Microbiol Infect Dis; 1990 Jan 14; 13(1):71-5. PubMed ID: 2331854 [Abstract] [Full Text] [Related]
12. Lomefloxacin (NY-198 or SC 47111): in vitro evaluations of a new fluoroquinolone. Diagn Microbiol Infect Dis; 1989 Jan 14; 12(3 Suppl):1S-105S. PubMed ID: 2791492 [No Abstract] [Full Text] [Related]
16. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae. Rossolini GM, Valentini S, Vaiani G, Satta G. J Chemother; 1989 Jul 14; 1(4 Suppl):173-6. PubMed ID: 16312356 [No Abstract] [Full Text] [Related]
17. In vitro activity of MF 5137, a new potent 6-aminoquinolone. Wise R, Pagella PG, Cecchetti V, Fravolini A, Tabarrini O. Drugs; 1995 Jul 14; 49 Suppl 2():272-3. PubMed ID: 8549329 [No Abstract] [Full Text] [Related]
18. Microbiological studies on lomefloxacin--a new quinolone. Newsom SW, Rowland C. J Chemother; 1989 Jul 14; 1(4 Suppl):168-9. PubMed ID: 16312354 [No Abstract] [Full Text] [Related]
19. Tricyclic fluoroquinolones as potential antimicrobial agents. Skotnicki JS, Steinbaugh BA, Strike DP. Drug Des Deliv; 1988 Nov 14; 3(3):257-61. PubMed ID: 3255331 [No Abstract] [Full Text] [Related]
20. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections]. Iakovlev SV. Urologiia; 2002 Nov 14; (1):11-4. PubMed ID: 11877963 [Abstract] [Full Text] [Related] Page: [Next] [New Search]